1	Añadir	añadir	VMN0000	-	-	0-6	107_ANS_clinical_caseMIR	SENT1	-	-
2	sulfato	sulfato	NCMS000	C0024480#C0772046_1	sustancia_1	7-14	107_ANS_clinical_caseMIR	SENT1	B-Grp_Medicamento	-
3	de	de	SPS00	C0024480#C0772046_2	sustancia_2	15-17	107_ANS_clinical_caseMIR	SENT1	I-Grp_Medicamento	-
4	magnesio	magnesio	NCMS000	C0024480#C0772046_3	sustancia_3	18-26	107_ANS_clinical_caseMIR	SENT1	I-Grp_Medicamento	-
5	.	.	Fp	-	-	26-27	107_ANS_clinical_caseMIR	SENT1	-	-

1	Aumentar	aumentar	VMN0000	-	-	0-8	107_ANS_clinical_caseMIR	SENT2	-	-
2	la	el	DA0FS0	-	-	9-11	107_ANS_clinical_caseMIR	SENT2	-	-
3	dosis	dosis	NCFN000	-	-	12-17	107_ANS_clinical_caseMIR	SENT2	-	-
4	de	de	SPS00	C0332285	atributo	18-20	107_ANS_clinical_caseMIR	SENT2	-	-
5	prednisona	prednisona	NCFS000	C0032952	sustancia	21-31	107_ANS_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
6	a	a	SPS00	-	-	32-33	107_ANS_clinical_caseMIR	SENT2	-	-
7	30	30	Z	-	-	34-36	107_ANS_clinical_caseMIR	SENT2	-	-
8	mg	mg	NCMN000	-	-	37-39	107_ANS_clinical_caseMIR	SENT2	-	-
9	/	/	Fh	-	-	39-40	107_ANS_clinical_caseMIR	SENT2	-	-
10	día	día	NCMS000	C0439228#C0332169	calificador	40-43	107_ANS_clinical_caseMIR	SENT2	-	-
11	.	.	Fp	-	-	43-44	107_ANS_clinical_caseMIR	SENT2	-	-

1	Añadir	añadir	VMN0000	-	-	0-6	107_ANS_clinical_caseMIR	SENT3	-	-
2	omalizumab	omalizumab	NC00SC0	C0966225	producto#sustancia	7-17	107_ANS_clinical_caseMIR	SENT3	B-Grp_Medicamento	-
3	.	.	Fp	-	-	17-18	107_ANS_clinical_caseMIR	SENT3	-	-

1	Pautar	pautar	VMN0000	-	-	0-6	107_ANS_clinical_caseMIR	SENT4	-	-
2	tratamiento	tratamiento	NCMS000	C1273870#C0087111	procedimiento#régimen/tratamiento	7-18	107_ANS_clinical_caseMIR	SENT4	-	-
3	nebulizado	nebulizado	VMP00SM	-	-	19-29	107_ANS_clinical_caseMIR	SENT4	-	-
4	en	en	SPS00	C1720294#C0332285	calificador#atributo	30-32	107_ANS_clinical_caseMIR	SENT4	-	-
5	el	el	DA0MS0	-	-	33-35	107_ANS_clinical_caseMIR	SENT4	-	-
6	domicilio	domicilio	NCMS000	C1442065	entidad_observable	36-45	107_ANS_clinical_caseMIR	SENT4	-	-
7	.	.	Fp	-	-	45-46	107_ANS_clinical_caseMIR	SENT4	-	-

1	Cambiar	cambiar	VMN0000	-	-	0-7	107_ANS_clinical_caseMIR	SENT5	-	-
2	a	a	SPS00	-	-	8-9	107_ANS_clinical_caseMIR	SENT5	-	-
3	una	una		C0205447_1	calificador_1	10-13	107_ANS_clinical_caseMIR	SENT5	-	-
4	combinación	combinación	NCFS000	C0205195#C0453882	calificador#objeto_físico	14-25	107_ANS_clinical_caseMIR	SENT5	-	-
5	con	con	SPS00	C0332287	atributo	26-29	107_ANS_clinical_caseMIR	SENT5	-	-
6	dosis	dosis	NCFN000	-	-	30-35	107_ANS_clinical_caseMIR	SENT5	-	-
7	altas	alto	AQ0FP0	C0205250	calificador	36-41	107_ANS_clinical_caseMIR	SENT5	-	-
8	de	de	SPS00	C0332285	atributo	42-44	107_ANS_clinical_caseMIR	SENT5	-	-
9	budesonida	budesonida	NC00SC0	C0054201	producto#sustancia	45-55	107_ANS_clinical_caseMIR	SENT5	B-Grp_Medicamento	-
10	y	y	CC	C1706368	calificador	56-57	107_ANS_clinical_caseMIR	SENT5	-	-
11	formoterol	formoterol	NC00SC0	C0060657	producto#sustancia	58-68	107_ANS_clinical_caseMIR	SENT5	B-Grp_Medicamento	-
12	.	.	Fp	-	-	68-69	107_ANS_clinical_caseMIR	SENT5	-	-

